NTES-S
09999
JD HEALTH
06618
TENCENT
00700
4
JD-SW
09618
5
BABA-W
09988
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.54%42.9B | 8.36%22.17B | 28.36%42.67B | 23.28%20.46B | 11.93%33.24B | 9.38%16.6B | 29.81%29.7B | 31.44%15.17B | -4.76%22.88B | --11.54B |
Operating income | 0.54%42.9B | 8.36%22.17B | 28.36%42.67B | 23.28%20.46B | 11.93%33.24B | 9.38%16.6B | 29.81%29.7B | 31.44%15.17B | -4.76%22.88B | 11.54B |
Cost of sales | -4.17%-17.98B | -12.12%-9.14B | -22.04%-17.26B | -20.58%-8.15B | -17.47%-14.14B | -13.94%-6.76B | -28.51%-12.04B | -28.04%-5.93B | 12.52%-9.37B | ---4.63B |
Operating expenses | -4.17%-17.98B | -12.12%-9.14B | -22.04%-17.26B | -20.58%-8.15B | -17.47%-14.14B | -13.94%-6.76B | -28.51%-12.04B | -28.04%-5.93B | 12.52%-9.37B | -4.63B |
Gross profit | -1.93%24.92B | 5.87%13.03B | 33.05%25.41B | 25.13%12.31B | 8.15%19.1B | 6.46%9.84B | 30.71%17.66B | 33.73%9.24B | 1.49%13.51B | 6.91B |
Selling expenses | 1.19%-9.17B | -5.88%-4.97B | -18.71%-9.28B | -30.01%-4.7B | -8.12%-7.82B | -1.62%-3.61B | -31.26%-7.23B | -31.92%-3.55B | 5.26%-5.51B | ---2.69B |
Administrative expenses | 9.25%-1.96B | 4.71%-913.38M | -17.83%-2.16B | -9.38%-958.57M | -4.81%-1.84B | -32.20%-876.35M | -32.20%-1.75B | 5.12%-662.88M | 4.20%-1.32B | ---698.62M |
Special items of operating profit | 14.88%2.1B | 15.17%1.03B | 8.34%1.83B | 21.05%897.93M | 129.48%1.69B | 127.10%741.79M | 87.58%735.03M | 6.47%326.63M | -2.66%391.84M | --306.78M |
Operating profit | 0.58%15.88B | 8.31%8.18B | 41.90%15.79B | 24.01%7.55B | 18.27%11.13B | 13.85%6.09B | 33.15%9.41B | 39.91%5.35B | 8.46%7.07B | 3.82B |
Financing cost | 8.29%-91.47M | -32.92%-39.44M | -31.18%-99.74M | -32.81%-29.67M | -43.60%-76.03M | 6.64%-22.34M | 32.95%-52.95M | 17.84%-23.93M | -408.62%-78.96M | ---29.13M |
Earning before tax | 0.64%15.79B | 8.21%8.14B | 41.97%15.69B | 23.97%7.52B | 18.13%11.05B | 13.94%6.07B | 33.90%9.35B | 40.35%5.33B | 7.50%6.99B | 3.8B |
Tax | -1.55%-3.66B | -8.80%-1.9B | -41.24%-3.61B | -19.71%-1.75B | -16.54%-2.56B | -11.19%-1.46B | -28.30%-2.19B | -41.15%-1.31B | -10.64%-1.71B | ---930.8M |
After-tax profit from continuing operations | 0.36%12.12B | 8.04%6.24B | 42.19%12.08B | 25.33%5.78B | 18.62%8.5B | 14.84%4.61B | 35.71%7.16B | 40.09%4.01B | 6.52%5.28B | 2.86B |
Earning after tax | 0.36%12.12B | 8.04%6.24B | 42.19%12.08B | 25.33%5.78B | 18.62%8.5B | 14.84%4.61B | 35.71%7.16B | 40.09%4.01B | 6.52%5.28B | 2.86B |
Profit attributable to shareholders | 0.36%12.12B | 8.04%6.24B | 42.19%12.08B | 25.33%5.78B | 18.62%8.5B | 14.84%4.61B | 35.71%7.16B | 40.09%4.01B | 6.65%5.28B | 2.86B |
Basic earnings per share | 0.37%1.078 | 7.84%0.55 | 41.32%1.074 | 24.39%0.51 | 18.75%0.76 | 13.89%0.41 | 33.33%0.64 | 33.33%0.36 | 4.35%0.48 | 0.27 |
Diluted earnings per share | 0.37%1.078 | 7.84%0.55 | 41.32%1.074 | 24.39%0.51 | 18.75%0.76 | 13.89%0.41 | 33.33%0.64 | 33.33%0.36 | 4.35%0.48 | 0.27 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.